Alendronate (Fosamax)

DRUG4 trials

Sponsors

Far Eastern Memorial Hospital, Medical University of South Carolina, University of Pittsburgh, ZhongShan LaiBo RuiChen BioMedicine Co.,Ltd.

Conditions

FracturesJuvenile OsteoporosisLow Bone DensityOsteonecrosisOsteonecrosis of the Femoral HeadOsteoporosis, Post-menopausalPeritoneal Dialysis

Phase 2

Romosozumab Effects on Bone Density, Muscle Mass, and Spine Surgery Outcomes

WithdrawnNCT06973109

University of PittsburghOsteoporosis, Post-menopausal

Start: 2026-06-20End: 2027-06-01Updated: 2026-06-04

A Phase II Trial of RAB001 (LLP2A-Alendronate) for Steroid-Induced Early-Stage Osteonecrosis of the Femoral Head

Active, not recruitingNCT07471880

ZhongShan LaiBo RuiChen BioMedicine Co.,Ltd.Osteonecrosis, Osteonecrosis of the Femoral Head

Start: 2024-12-24End: 2027-02-28Updated: 2026-03-24

Phase 4

Alendronate for Vascular Calcification in Peritoneal Dialysis Patients?

Far Eastern Memorial HospitalPeritoneal Dialysis

Start: 2006-03-31End: 2006-12-31Target: 50Updated: 2006-03-07

Unknown Phase

Alendronate in Juvenile Osteoporosis

CompletedNCT00920075

Medical University of South CarolinaFractures, Juvenile Osteoporosis, Low Bone Density

Start: 2009-07-31End: 2010-10-31Updated: 2018-07-11